Dive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it has agreed to pay $1 billion to...
Medicine
Dive Brief: Sales of Novo Nordisk’s obesity drug Wegovy slowed over the first three months of 2024, compared to the...
Cancer research is always evolving, as scientists search for ways to combat the tricks tumors use to evade drug therapies....
Dive Brief: GSK on Wednesday raised its financial forecasts for the year following strong quarterly sales of its vaccines and...
Federal officials said a new rule expanding regulatory oversight of laboratory-developed tests will protect patients from inaccurate results while maintaining...
Eli Lilly expects that, by the second half of this year, it will be able to manufacture at least 50%...
One study can start a pharmaceutical revolution. Four years ago, a large clinical trial run by Novo Nordisk showed a...
Dive Brief: The Food and Drug Administration on Monday released a final rule strengthening its authority over laboratory developed tests,...
Dive Brief: Repertoire Immune Medicines, a biotechnology startup formed by Flagship Pioneering, announced Monday a deal with Bristol Myers Squibb...
Dive Brief: Biogen has seen “encouraging early trends” in the launch of its postpartum depression pill Zurzuvae, revealing in first...